
Conference Coverage
Latest Content

Top 5 Most-Read Mental Health Content of 2025

In-Home Step Training Did Not Improve Proprioception, Muscle Performance in MS

Top 5 Most-Read Allergy Content of 2025

Patient-Reported Outcomes Highlight Impacts of Chronic Inducible Cold Urticaria

Health System Barriers, Treatment Disparities Prolong gMG Diagnosis

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

From oncology to cardiology, Institute for Value-Based Medicine® conversations highlighted the ways value-based care is reshaping access, equity, and outcomes.

Our top 5 heart failure content of 2025 include FDA approvals, GDMT optimization, risk markers like LBBB and SDOH, and value-based care models improving outcomes in heart failure.

The final AJMC Stakeholder Interchange of 2025 took place in Seattle, Washington.

Chronic kidney disease complicates cancer treatment, leading to reduced chemotherapy use. Personalized approaches are essential for optimal patient outcomes.

Scott Soefje, PharmD, MBA, BCOP, of Mayo Clinic, discusses how payer-provider collaboration and pharmacist-led management can help improve oncology care.

Readers of PHEO this year found value in research, conference coverage, and insights that touched on health outcomes and care quality.

Obstructive sleep apnea may increase Parkinson disease risk, but early CPAP treatment could significantly reduce this risk.

Our conference coverage featured updates on clinical trials testing new treatments for NSCLC, bladder cancer, and breast cancer.

Heart failure deaths increasingly occur at home or in hospice, but racial, sex, and regional disparities persist in end-of-life care.

The FDA approves Wegovy, the first oral GLP-1 pill, offering a new weight loss solution for those struggling with obesity and overweight.



















































